CVS
45
-4
CCL
68
-4
HRL
30
-5
LLY
48
-2
RF
51
-2
GME
63
12
EL
30
-3
BIIB
37
7
AIV
71
9
PSX
40
-4
NWSA
47
-2
SWN
77
4
AN
50
-5
AMP
66
-4
T
56
2
WEC
45
2
AEE
61
3
PPL
65
6
VLO
40
-5
BF.B
43
-7
CVS
45
-4
CCL
68
-4
HRL
30
-5
LLY
48
-2
RF
51
-2
GME
63
12
EL
30
-3
BIIB
37
7
AIV
71
9
PSX
40
-4
NWSA
47
-2
SWN
77
4
AN
50
-5
AMP
66
-4
T
56
2
WEC
45
2
AEE
61
3
PPL
65
6
VLO
40
-5
BF.B
43
-7
Financhill
Back

Sarepta Therapeutics Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
127.17
Seasonality Move:
0.19%

7 Day Trial

ALL ACCESS PASS

$ 7

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sarepta Therapeutics Stock Forecast

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 21.2% based on the past 27 years of stock performance.
  • Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Sarepta Therapeutics Stock Undervalued?
    The current Sarepta Therapeutics [SRPT] share price is $127.17. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 21.2% based on the past 27 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

  • Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com

52-Week Data

52-Week High:
173.25
52-Week Low:
55.25

Prediction Charts

Market Cap:
12.13B
Price in USD:
127.17
Volume:
710.4K
Beta:
1.06

Technical Analysis

SMA50:
137.60
SMA100:
136.02
SMA200:
126.61
52-Wk Change:
7.8%

Stock Predictions

  • Is Sarepta Therapeutics stock public?
    Yes, Sarepta Therapeutics is a publicly traded company.
  • What is the Sarepta Therapeutics stock quote today?
    The Sarepta Therapeutics stock price is 127.17 USD today.
  • How to buy Sarepta Therapeutics stock online?
    You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 135.45 135.06 138.71 133.97
Sep-4 133.96 134.79 135.38 132.72
Sep-5 134.84 133.83 135.27 133.22
Sep-6 134.00 128.96 134.55 126.82
Sep-9 128.51 127.70 129.93 127.29
Sep-10 127.57 126.94 127.86 124.71
Sep-11 126.46 128.42 128.59 125.34
Sep-12 128.00 125.37 128.00 124.49
Sep-13 124.12 124.65 125.95 120.42
Sep-16 125.76 124.33 126.67 123.91
Sep-17 124.78 125.69 127.36 124.32
Sep-18 126.07 125.01 128.08 123.61
Sep-19 126.41 127.10 128.65 125.61
Sep-20 127.10 127.17 129.01 125.05

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.